Public Policy
Letter to Senator Tom Harkin in Support of the “Healthy Families Act”
We strongly support the “Healthy Families Act.” Thank you for sponsoring this important legislation, which would create a national standard for paid sick days. Read More
Letter to Congresswoman Rosa DeLauro in Support of the “Healthy Families Act”
We strongly support the “Healthy Families Act.” Thank you for sponsoring this important legislation, which would create a national standard for paid sick days. Read More
Statement of Dr. Diana Zuckerman Regarding Legislation to Require Warning Letters to Women with Dense Breasts To Nevada Assembly
March 11, 2013. Among experts in women’s health and experts in breast cancer, there is considerable concern about Assembly Bill 147 and similar legislation in other states. While we agree that women with dense breasts should discuss the implications of that health condition with their physician, we are concerned that women who receive required form letters are more frightened than informed. Read More
Testimony of Dr. Mary Carol Jennings to the FDA Joint Advisory Committee of the FDA on Calcitonin
Dr. Jennings testifies to the FDA that the risks of using calcitonin to prevent bone fractures in post-menopausal are greater than the potential benefits. Read More
Testimony of Dr. Mary Carol Jennings to the Reproductive Health Drugs Advisory Committee of the FDA on Paroxetine
Dr. Mary Carol Jennings testifies to the FDA on the risks of using Paroxetine to treat hot flashes. Read More
Testimony of Dr. Mary Carol Jennings to the Reproductive Health Drugs Advisory Committee of the FDA on Gabapentin
Dr. Jennings testifies to the FDA that there is not sufficient evidence to support gabapentin as a safe and effective treatment for hot flashes. Read More
Statement of Dr. Jennifer Yttri at the public hearing on Creating an Alternative Approval Pathway for Certain Drugs Intended to Address Unmet Medical Need
Dr. Yttri testifies at an FDA public hearing that a new, expedited pathway for drug approval is poorly-defined and would promote unproven drugs to high-risk patients. Read More
Letter to Representative Henry A. Waxman Regarding Draft Proposal of the Data Act of 2012
The National Research Center for Women & Families supports the Data Act and shares concerns about the current and growing risk of antibacterial resistance to medically important drugs as a consequence of agricultural practices. Read More
Letter to HELP Committee on Track and Trace Legislation
We are deeply concerned about the current and growing risk to the U.S. pharmaceutical supply, a threat that can best be addressed through a meaningful national system to track and authenticate pharmaceutical products as they move from manufacturer to wholesaler to pharmacy to patient. Read More
Letter to CMS urging the release of the Sunshine Act final regulations
As members of the Patient, Consumer, and Public Health Coalition, we strongly urge CMS to release the Sunshine Act final regulations as quickly as possible. Read More